Note: Ingredients listed on restricted chemical lists
EC/CAS
7440-02-0
Name of the chemical
Nickel
Concentration
65-69
EC/CAS
7440-44-0
Name of the chemical
Carbon black
Concentration
31-35
EC/CAS
7440-48-4
Name of the chemical
Cobalt, Metall (2020/217)
Concentration
0.1-0.3
General Information
Revision date
2014-08-06
Product name
E-Fill 2901
supplier name
Oerlikon Metco (US) Inc
Emergency telephone
800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
Oerlikon Metco (US) Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Emergency overview Physical state Solid. Color : Gray. Odor : Odorless.
Signal word
WARNING!
Hazard statements
CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY CAUSE ALLERGIC RESPIRATORY AND SKIN REACTION. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. CANCER HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE CANCER.
Precautionary statements
Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe dust. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation Irritating to respiratory system. May cause sensitization by inhalation. Ingestion No known significant effects or critical hazards. Skin Irritating to skin. May cause sensitization by skin contact. Eyes Irritating to eyes.
Potential chronic health
effects : Contains material that can cause target organ damage. Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity : Contains material which can cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: kidneys, lungs, upper respiratory tract, skin, nose/sinuses. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing wheezing and breathing difficulties asthma Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing respiratory and skin disorders and disorders involving any other target aggravated by over- organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to exposure this product. See toxicological information (Section 11)